Upgrade to SI Premium - Free Trial

RADX (RADX)

0.98 -0.01 (1.01%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)

Latest Headlines

Form 6-K Radiopharm Theranostics For: Oct 20 October 20, 2026 6:08 AM - SEC Filing Form SCHEDULE 13G Radiopharm Theranostics Filed by: Regal Partners Funds Management Pty Ltd October 14, 2026 9:16 PM - SEC Filing Radiopharm completes FDA end-of-phase 2 meeting for RAD101 October 5, 2026 8:01 AM - StreetInsider Form 6-K Radiopharm Theranostics For: Oct 05 October 5, 2026 8:00 AM - SEC Filing Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101 October 5, 2026 8:00 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Oct 01 October 1, 2026 8:00 AM - SEC Filing Form 20-F Radiopharm Theranostics For: Jun 30 September 30, 2026 3:16 PM - SEC Filing Form 6-K Radiopharm Theranostics For: Sep 30 September 30, 2026 6:08 AM - SEC Filing Form EFFECT Radiopharm Theranostics September 24, 2026 6:02 AM - SEC Filing Form 424B3 Radiopharm Theranostics September 23, 2026 4:50 PM - SEC Filing Form 6-K Radiopharm Theranostics For: Sep 22 September 22, 2026 8:00 AM - SEC Filing Radiopharm RAD101 brain imaging data selected for SNO26 presentation September 14, 2026 8:02 AM - StreetInsider Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting September 14, 2026 8:00 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Sep 14 September 14, 2026 6:11 AM - SEC Filing Form F-3 Radiopharm Theranostics September 14, 2026 6:09 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Sep 11 September 11, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Aug 28 August 28, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Aug 27 August 27, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Aug 26 August 26, 2026 8:00 AM - SEC Filing Radiopharm doses first patient in second RV-01 trial cohort August 26, 2026 7:00 AM - StreetInsider Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors August 26, 2026 7:00 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Aug 20 August 20, 2026 8:00 AM - SEC Filing Radiopharm trial advances to higher dose in HER2+ cancer study August 20, 2026 7:01 AM - StreetInsider Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial August 20, 2026 7:00 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Aug 17 August 17, 2026 8:00 AM - SEC Filing Radiopharm sets FDA meeting for RAD101 brain metastases trial design August 17, 2026 7:30 AM - StreetInsider Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases August 17, 2026 7:30 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Aug 13 August 13, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Jul 24 August 3, 2026 8:49 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Aug 03 August 3, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Jul 31 July 31, 2026 8:00 AM - SEC Filing Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases July 31, 2026 7:01 AM - StreetInsider Radiopharm Theranostics Reports Business Update July 31, 2026 7:00 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Jul 28 July 28, 2026 11:59 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Jul 28 July 28, 2026 8:00 AM - SEC Filing Form 6-K Radiopharm Theranostics For: Jul 27 July 27, 2026 6:06 AM - SEC Filing Form 424B5 Radiopharm Theranostics July 27, 2026 6:03 AM - SEC Filing Radiopharm raises up to $13M via US and Australian offerings July 24, 2026 7:15 AM - StreetInsider Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan July 24, 2026 7:15 AM - Globe NewsWire Form 6-K Radiopharm Theranostics For: Jul 24 July 24, 2026 7:00 AM - SEC Filing Form 424B5 Radiopharm Theranostics July 23, 2026 9:09 AM - SEC Filing Full Article List